Second primary melanomas on treatment with vemurafenib: reply from the authors. | Br J Dermatol;168(4): 888-9, 2013 Apr. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

Brasil - Virtual Health Library

Information and Knowledge for Health

Subject descriptor lookup Advanced Search

Second primary melanomas on treatment with vemurafenib: reply from the authors.

Fearfield, L; Newton-Bishop, J A; Sinha, R; Edmonds, K; Gore, M E; Larkin, J.

Br J Dermatol ; 168(4): 888-9, 2013 Apr.

Article in En | MEDLINE | ID: mdl-23066884

Subject(s)

Drug Eruptions/etiology; Indoles/adverse effects; Melanoma/drug therapy; Protein Kinase Inhibitors/adverse effects; Proto-Oncogene Proteins B-raf/antagonists & inhibitors; Skin Neoplasms/drug therapy; Sulfonamides/adverse effects; Humans

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Sulfonamides / Drug Eruptions / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / Indoles / Melanoma Limits: Humans Language: En Journal: Br J Dermatol Year: 2013 Document type: Article

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Sulfonamides / Drug Eruptions / Proto-Oncogene Proteins B-raf / Protein Kinase Inhibitors / Indoles / Melanoma Limits: Humans Language: En Journal: Br J Dermatol Year: 2013 Document type: Article